NCT07245069
- Conditions
- Anthracycline-induced Cardiac Toxicity, Arterial Stiffness, Breast Cancer, +13 more
- Locations
-
- University Medical Centre Ljubljana Ljubljana, Slovenia
Clinical trial condition
Anthracycline-induced Cardiac Toxicity
Explore clinical trials studying Anthracycline-induced Cardiac Toxicity. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Anthracycline-induced Cardiac Toxicity trial results
NCT05223413
- Conditions
- Anthracycline-induced Cardiac Toxicity, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Aarhus University Aarhus, Denmark
- Hospital Jaques Monod, El Havre Montivilliers, France
- Henri Becquerel Rouen, France
- University Hospital Duesseldorf UDUS Düsseldorf, Germany
Not Yet Recruiting
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
NCT07254221
- Conditions
- Anthracycline Related Cardiotoxicity in Breast Cancer, Anthracycline-induced Cardiac Toxicity, Anthracycline-induced Cardiotoxicity, +16 more
- Locations
-
- Motahari Breast Cancer Clinic Shiraz, Fars, Iran
- Kowsar Hospital, Fars Heart Foundation Shiraz, Fars, Iran
- Toba Oncology Department, Mazandaran University of Medical Sciences Sari, Mazandaran, Iran
- Modarres Hospital, Shahid Beheshti University of Medical Sciences Tehran, Tehran Province, Iran